FDA approves BESREMi for adults with essential thrombocythemia, offering a new treatment option for people living with this ...
Morning Overview on MSN
A newly approved protein-shredding drug gives myeloma patients another option
A newly approved cancer drug takes an unusual approach to treating multiple myeloma: instead of blocking a harmful protein, ...
A new study shows that epitranscriptomics, or chemical regulation of gene expression at the RNA level, determines whether ...
Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...
Discover essential information about Chronic Lymphocytic Leukemia (CLL), its diagnosis, symptoms, and treatment options in ...
These are heady days for PharmaEssentia, a biotech that got its start 23 years ago in Taiwan, went public 10 years later and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results